Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Luci vs UR Meds

Luci
Graded #99

Higher grade

vs+16.1
UR Meds
Graded #452

Lower grade

The verdict

Luci takes it — 71/100 to 54.9/100.

Luci grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Luci is a budget-focused GLP-1 telehealth platform offering compounded medications with upfront pricing: compounded semaglutide as low as $99/month and compounded tirzepatide as low as $145/month, plus oral…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLuci +39
84
45
Dose & formulationLuci +35
75
40
Clinical oversightUR Meds +7
71
78
Labs & monitoringEven
53
53
FulfillmentLuci +6
70
64
Contract termsEven
55
55
Luci · left barUR Meds · right bar

The numbers

MetricLuciUR Meds
WeighScore71/10054.9/100
GradeCC
Scorecard rank#99#452
Semaglutide$99/mo (starting dose, promotional rate, compounded)Not disclosed
Tirzepatide$145/mo (starting dose, promotional rate, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Luci

Graded #99 · C

Strengths

  • Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
  • Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
  • Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
  • Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
  • HIPAA-compliant platform with a large self-reported member base (50,000+)

Where it loses points

  • Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Available only in select U.S. states, and the full state list is not published
  • The compounding pharmacy partner is not named
  • Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
  • No LegitScript certification displayed; marketing leans heavily on testimonials
UR Meds

Graded #452 · C

Strengths

  • GLP-1 weight-loss care from $179/mo with the same price at every dose
  • No monthly membership; cancel anytime; no insurance required
  • Multi-pillar: also peptides, men's/women's health, hair, and longevity
  • Runs on the OpenLoop Health telehealth platform with US-licensed providers
  • 10,000+ patients served

Where it loses points

  • Specific GLP-1 molecule (semaglutide vs tirzepatide) not named on the marketing site
  • Compounding pharmacy partner not named
  • States of operation not published
  • LegitScript 'Certified' shown via a self-hosted badge linking to the generic LegitScript site (not independently verifiable)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard